Novo Nordisk Strikes $6.3M Deal To End Feds' FCA Claims
Novo Nordisk Inc. has agreed to pay the United States $6.3 million to resolve allegations the global pharmaceutical firm sold needles under U.S. Department of Veterans Affairs supply contracts that were...To view the full article, register now.
Already a subscriber? Click here to view full article